A recent Forbes article explores the prevalence of “Low-T” drug ads by companies like AbbVie and Eli Lilly & Co., and how two men’s health experts think the advertisements should be banned.
Testosterone therapy products have been associated with an increased risk of serious cardiovascular health effects. A study published in November 2013 linked testosterone therapy to increased rates of heart attack, stroke, and ...
continue reading...According to the website of the U.S. District Court for the Northern District of Illinois, the multidistrict testosterone therapy litigation MDL 2545 now includes 1,530 testosterone lawsuits—nearly 200 more than it did just one month ago. The multidistrict testosterone litigation was established in June 2014, and initially consisted of eight separate testosterone lawsuits. Testosterone lawsuits claim that testosterone therapy products from companies like AbbVie and Eli Lilly ...
Antares Pharma Incorporated saw dramatic falls in its stock price after hitting a roadblock in clinical trials of its prescription testosterone product. A patient developed an allergic reaction to the drug during the trial, causing the U.S. Food and Drug Administration (FDA) to request additional safety information. A Reuters’ article discusses the setback for the testosterone therapy manufacturer.
Concerns over the safety of prescription testosterone products have ...
continue reading...First Word Pharma reports that Androgel maker AbbVie has abandoned its plan to buy out pharmaceutical maker Shire. AbbVie says the bid for Shire was withdrawn in light of recent U.S. tax law changes. As a result of the failed deal, AbbVie will have to pay $1.6 billion to Shire and will be unable to make another offer to purchase the company for at least a year.
The Androgel maker was recently in the news over ...
continue reading...
A recent story posted by MedlinePlus notes new guidelines from the Endocrine Society. The guidelines say no testosterone therapy for women as the benefits are not clear and the risks of testosterone therapy are unknown in women.
Although there is some research indicating that testosterone therapy may be helpful to sexual function in menopausal women, a statement by the Endocrine Society says there are too many unanswered questions about the risks of testosterone therapy in ...
continue reading...A possible link between testosterone therapy and increased heart risks has prompted much debate recently. A recent Bloomberg news article talks about ongoing discussions over the safety and effectiveness of testosterone therapy drugs.
One study, published in January of 2014, showed that testosterone therapy may lead to an increased risk of heart attack in men aged 65 and older, as well as in younger men with a history of heart disease. Of a group of ...
continue reading...
